BACKGROUND: Type 2 diabetes is associated with a substantially increased risk of cardiovascular disease, but the role of lipid-lowering therapy with statins fo...
作者:国际循环网 发布于:2004-09-16
From 1600 consecutive CHD patients randomized to either form of care in the GREek Atorvastatin and CHD Evaluation Study (GREACE), 313 had DM: 161 in the struct...
BACKGROUND: Little is known about statins in the prevention of dyslipidaemia induced renal function decline. The secondary coronary heart disease (CHD) preventi...
Objective: To compare early initiation of an intensive statin regimen with delayed initiation of a less intensive regimen in patients with ACS. Design, Setting...
OBJECTIVE: Irbesartan was renoprotective independently of its blood pressure-lowering effect in the Irbesartan in Patients With Type 2 Diabetes and Microalbumin...
作者:RossingK,ChristensenPK 发布于:2004-09-16
BACKGROUND: Present angiotensin-converting-enzyme inhibitor treatment fails to prevent progression of non-diabetic renal disease. We aimed to assess the efficac...
作者:国际循环网 发布于:2004-08-24
BACKGROUND: Most cardiovascular events associated with hypertension are complications of atherosclerosis. Some antihypertensive agents influence experimental mo...
作者:ZanchettiA,BondMG,HennigM 发布于:2004-08-24
ISC中国之声丨脑卒中康复住院患者,恢复..
AHA科学声明:成人颈动脉夹层的治疗和结..
新诊断HFrEF患者GDMT治疗存在性别差异,..
患有抑郁的心衰患者,选择心理治疗还是..